Microfluidic, one-hour, total anti-AAV2 antibody assay inhuman serum using Gyrolab platform

This poster presents the development of an immunoassay for the detection of total AAV2 anti-capsid antibodies (TAbs) using the Gyrolab® platform, for rapid and accurate rapid and accurate measurement of immunogenicity against adeno-associated viral (AAV) vector serotypes

If you have problems downloading the poster, please contact maritha.lundin@gyrosproteintech.com